Gene · 4350
Papers2,085
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,085
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The in vivo Interaction Landscape of Histones H3.1 and H3.3. | Mol Cell Proteomics | 2022 | 36089195 | PubTator, text mining | PubMed |
| PREvalence Study on Surgical COnditions (PRESSCO) 2020: A Population-Based Cross-Sectional Countrywide Survey on Surgical Conditions in Post-Ebola Outbreak Sierra Leone. | World J Surg | 2022 | 36068404 | PubTator, text mining | PubMed |
| Redox regulation of RAD51 Cys319 and homologous recombination by peroxiredoxin 1. | Redox Biol | 2022 | 36058112 | PubTator, text mining | PubMed |
| Whole-exome sequencing expands the roles of novel mutations of organic anion transporting polypeptide, ATP-binding cassette transporter, and receptor genes in intrahepatic cholestasis of pregnancy. | Front Genet | 2022 | 36046230 | PubTator, text mining | PubMed |
| Review: New horizons in retinoblastoma treatment: an updated review article. | Mol Vis | 2022 | 36034735 | PubTator, text mining | PubMed |
| Efficient DNA fluorescence labeling via base excision trapping. | Nat Commun | 2022 | 36028479 | PubTator, text mining | PubMed |
| Research Progress on the Role of RNA m6A Modification in Glial Cells in the Regulation of Neurological Diseases. | Biomolecules | 2022 | 36009052 | PubTator, text mining | PubMed |
| Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials. | Bioengineering (Basel) | 2022 | 36004931 | PubTator, text mining | PubMed |
| Deep sequencing of short capped RNAs reveals novel families of noncoding RNAs. | Genome Res | 2022 | 35961773 | PubTator, text mining | PubMed |
| The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma. | Front Immunol | 2022 | 35958561 | PubTator, text mining | PubMed |
| Regulation of Amylose Content by Single Mutations at an Active Site in the Wx-B1 Gene in a Tetraploid Wheat Mutant. | Int J Mol Sci | 2022 | 35955567 | PubTator, text mining | PubMed |
| Role of m6A writers, erasers and readers in cancer. | Exp Hematol Oncol | 2022 | 35945641 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Unpaved roads: How the DNA damage response navigates endogenous genotoxins. | DNA Repair (Amst) | 2022 | 35939975 | PubTator, text mining | PubMed |
| Novel interaction interfaces mediate the interaction between the NEIL1 DNA glycosylase and mitochondrial transcription factor A. | Front Cell Dev Biol | 2022 | 35938152 | PubTator, text mining | PubMed |
| Early-onset diabetes involving three consecutive generations had different clinical features from age-matched type 2 diabetes without a family history in China. | Endocrine | 2022 | 35921062 | PubTator, text mining | PubMed |
| Necroptosis Identifies Novel Molecular Phenotypes and Influences Tumor Immune Microenvironment of Lung Adenocarcinoma. | Front Immunol | 2022 | 35911707 | PubTator, text mining | PubMed |
| Future of Digital Assays to Resolve Clinical Heterogeneity of Single Extracellular Vesicles. | ACS Nano | 2022 | 35904433 | PubTator, text mining | PubMed |
| Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review. | Clin Kidney J | 2022 | 35892014 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Quantification of the Antigens in Aluminum Hydroxide-Adjuvanted Diphtheria-Tetanus-Acellular-Pertussis Combination Vaccines. | Vaccines (Basel) | 2022 | 35891242 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4350/papers?page=15